
MASIERO LAURA
- U09, Floor: 1, Room: 1002
Publications
Grassilli, E., Pisano, F., Cialdella, A., Bonomo, S., Missaglia, C., Cerrito, M., et al. (2016). A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation. ONCOGENE, 35(33), 4368-4378 [10.1038/onc.2015.504]. Detail
Cerrito, M., Giovannoni, R., Grassilli, E., Lavitrano, M., Masiero, L., Pisano, F., et al. (2014)Combinations of a btk inhibitor and fluorouracil for treating cancers. Brevetto No. PCT/EP2014/066724. Detail
Grassilli, E., Ianzano, L., Bonomo, S., Missaglia, C., Cerrito, M., Giovannoni, R., et al. (2014). GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis. PLOS ONE, 9(7) [10.1371/journal.pone.0100947]. Detail
Cerrito, M., Giovannoni, R., Grassilli, E., Lavitrano, M., Masiero, L., Pisano, F., et al. (2013)Pharmaceutical kit for use in the treatment of colon and colorectal cancer. Brevetto No. EP2013179049.5. Detail
Grassilli, E., Narloch, R., Federzoni, E., Ianzano, L., Pisano, F., Giovannoni, R., et al. (2013). Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy. CLINICAL CANCER RESEARCH, 19(14), 3820-3831 [10.1158/1078-0432.CCR-12-3289]. Detail